MAP2K1 and breast carcinoma: Since the PI3K–Akt and MAP kinase signaling networks play important roles in breast cancer proliferation and survival, we investigated whether inhibition of PI3K or Mek1/2 would potentiate atorvastatin in breast cancer co-culture with primary human hepatocytes.